drugset / Trial / NCT02387866
PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects
Non-randomizedParallel-groupOpen-labelOther
Summary
This is a single ascending dose, open-label study that will evaluate the pharmacokinetics and safety of the AG-221 compound in normal, healthy volunteer male subjects (both Japanese and Caucasian).
Timeline
- Start
- 2015-03-02
- Primary completion
- 2015-05-21
- Completion
- 2015-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enasidenib | Small molecule | 50 mg | Oral |
| Subject | Enasidenib | Small molecule | 100 mg | Oral |
| Subject | Enasidenib | Small molecule | 300 mg | Oral |
Indications
No indication recorded.